Medpace Holdings (MEDP) Revenue (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Revenue came in at $707.3 million in Q2 2026, up 17.24% on a YoY basis from $603.3 million in Q2 2025, and little changed quarter-over-quarter from $706.6 million in Q1 2026.
Analysis
Medpace Holdings (MEDP) Revenue (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has reported Revenue for 12 consecutive years, with $707.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Revenue rose 17.24% year-over-year to $707.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.8 billion (up 24.67% YoY), and the FY2025 full-year result was $2.5 billion, up 19.97% from the prior year.
- Revenue held at $707.3 million in Q2 2026 per MEDP's latest filing, from $706.6 million in the prior quarter.
- Across five years, Revenue topped out at $708.4 million in Q4 2025 and bottomed at $330.9 million in Q1 2022.
- Historically, Revenue has averaged $522.2 million across 5 years, with a median of $519.6 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Revenue advanced 7.66% in 2024, then soared 32.03% in 2025.
- Over 5 years, Revenue stood at $394.1 million in 2022, then gained by 26.47% to $498.4 million in 2023, then rose by 7.66% to $536.6 million in 2024, then jumped by 32.03% to $708.4 million in 2025, then slipped by 0.16% to $707.3 million in 2026.
- According to Business Quant data, Revenue over the past three periods registered $707.3 million, $706.6 million, and $708.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 4.37 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 707.33 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.06 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.00 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 678.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 20.16 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 15.23 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 2.75 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 18,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 707.33 Mn |
| Mar 31, 2026 | 706.60 Mn |
| Dec 31, 2025 | 708.45 Mn |
| Sep 30, 2025 | 659.90 Mn |
| Jun 30, 2025 | 603.31 Mn |
| Mar 31, 2025 | 558.57 Mn |
| Dec 31, 2024 | 536.59 Mn |
| Sep 30, 2024 | 533.32 Mn |
| Jun 30, 2024 | 528.10 Mn |
| Mar 31, 2024 | 511.04 Mn |
| Dec 31, 2023 | 498.40 Mn |
| Sep 30, 2023 | 492.50 Mn |
| Jun 30, 2023 | 460.87 Mn |
| Mar 31, 2023 | 434.07 Mn |
| Dec 31, 2022 | 394.10 Mn |
| Sep 30, 2022 | 383.74 Mn |
| Jun 30, 2022 | 351.21 Mn |
| Mar 31, 2022 | 330.95 Mn |
| Dec 31, 2021 | 308.55 Mn |
| Sep 30, 2021 | 295.57 Mn |